Atrial fibrillation in patients with haemophilia: a cross‐sectional evaluation in Europe
- 14 April 2014
- journal article
- Published by Wiley in Haemophilia
- Vol. 20 (5), 682-686
- https://doi.org/10.1111/hae.12445
Abstract
Atrial fibrillation (AF) is a common health problem in the general population, but data on prevalence or management in patients with haemophilia (PWH) are lacking. The aims of this study were to analyse the prevalence of AF and risk factors for stroke using a cross-sectional pan-European design and to document current anticoagulation practice. The ADVANCE Working Group consists of members from 14 European haemophilia centres. Each centre retrieved data on their PWH with AF. From the total of 3952 adult PWH, 33 had AF with a mean age of 69 years (IQR 62-76). Haemophilia was severe in seven (21%), moderate in six (18%) and mild in 20 (61%) patients. The overall AF prevalence was 0.84% and increased with age; 0.42% in patients 40-60 years and 3.4% in patients >60 years. The mean CHA2 DS2 -Vasc score was 1.3 (range 0-4), predominantly determined by age and hypertension. Hypertension was reported in 48% of PWH with AF. In 11 patients (33%), anticoagulation was started of whom nine aspirin and two vitamin K antagonists. Of these 11 patients, nine had mild haemophilia. Anticoagulation was given in 42% of patients with a CHA2 DS2 -Vasc score ≥2. During follow-up (mean 57 months), there were no thrombotic events reported, nor increases in bleeding severity. The prevalence of AF in haemophilia increases with age and is predominantly present in mild haemophilia. PWH have a low stroke risk based on their CHA2 DS2 -Vasc scores, that might be even lower considering the hypocoagulable state. Only 33% of PWH with AF receives any form of anticoagulation therapy.Keywords
Funding Information
- Bayer HealthCare
This publication has 21 references indexed in Scilit:
- Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations)Journal of the American College of Cardiology, 2013
- Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patientsEP Europace, 2012
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)European Heart Journal, 2010
- Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapyJournal of Thrombosis and Haemostasis, 2009
- Cardiovascular disease in patients with hemophiliaJournal of Thrombosis and Haemostasis, 2009
- Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIVBlood, 2007
- Mortality and causes of death in patients with hemophilia, 1992–2001: a prospective cohort studyJournal of Thrombosis and Haemostasis, 2006
- Antithrombotic Therapy in Atrial FibrillationSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2004
- Validation of Clinical Classification Schemes for Predicting StrokeJama-Journal Of The American Medical Association, 2001
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJama-Journal Of The American Medical Association, 2001